ACE2 and cardiovascular disorder: As previously discussed, evidence suggests that patients with noncommunicable diseases such as diabetes, hypertension, cardiovascular disease, and chronic kidney disease have increased Angiotensin-Converting Enzyme 2 (ACE2) receptor expression, which facilitates SARS-CoV-2 entry in the host and thus increases disease severity and mortality [5].